Differential Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on COVID-19

BACKGROUND: The effect of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs) on the coronavirus disease 2019 (COVID-19) remains controversial from clinic evidence. OBJECTIVES: The objectives of this study were to report the major characteristics and clinical outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Lianjiu, Zhang, Jiahao, Jiang, Nanhui, Yang, Jie, He, Li, Xie, Qin, Huang, Rong, Wang, Fengqin, Kashani, Kianoush B., Sun, Zhongyi, Lu, Qiaofa, Peng, Zhiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070588/
http://dx.doi.org/10.4103/2665-9190.329042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070588/
http://dx.doi.org/10.4103/2665-9190.329042

Ejemplares similares